Related references
Note: Only part of the references are listed.EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis
Tong-Chun Xue et al.
BMC GASTROENTEROLOGY (2013)
Cancer Stem Cells Activate STAT3 the EZ Way
Shaun D. Fouse et al.
CANCER CELL (2013)
Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection
Yun-Fan Sun et al.
HEPATOLOGY (2013)
Binding and isolation of tumor cells in biological media with perfluorocarbon microbubbles
Guixin Shi et al.
METHODS (2013)
Epithelial cell adhesion molecule expression (CD326) in cancer: A short review
Carlo Patriarca et al.
CANCER TREATMENT REVIEWS (2012)
Significance of EpCAM and TROP2 expression in non-small cell lung cancer
Min Gyoung Pak et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2012)
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study
Jun Luo et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population
Lan Jiang et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
Markus Munz et al.
CANCER RESEARCH (2009)
EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
Taro Yamashita et al.
GASTROENTEROLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Epithelial cell adhesion molecule - More than a carcinoma marker and adhesion molecule
Monika Trzpis et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Hearing silence: non-neutral evolution at synonymous sites in mammals
JV Chamary et al.
NATURE REVIEWS GENETICS (2006)
EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy
WA Osta et al.
CANCER RESEARCH (2004)
A tumor-associated glycoprotein that blocks MHC class II-dependent antigen presentation by dendritic cells
R Gutzmer et al.
JOURNAL OF IMMUNOLOGY (2004)
Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak
MJ Winter et al.
EXPERIMENTAL CELL RESEARCH (2003)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Share Paper
